IQYMUNE
Laboratoire Francais Du Fractionnement Et Des Biotechnologies
Mark For: IQYMUNE® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79348835 |
| Registration Number | 1205643 |
| Mark Literal Elements | IQYMUNE |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) 2022-09-01 |
| Basis | 66(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | Yes |
| Current Basis | No |
| No Basis | No |
Timeline
| 2014-04-23 | Trademark Registered |
| 2022-08-11 | Application Filed |
| 2022-09-01 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2022-09-01 | Status: Live/Pending |
| 2022-09-01 | Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information. |
| 2022-09-02 | Transaction Date |
Trademark Parties (Applicants & Owners)
| Party: |  LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES |
| Address | 3 avenue des Tropiques F-91940 LES ULIS FRANCE |
| Legal Entity Type | Unknown |
| Legal Entity State | NOT PROVIDED |
Documents
 Application | 2022-09-01 | |
| Drawing | 2022-09-01 | |
| Filing Receipt Trademark Application | 2022-09-06 |
Attorney of Record
Good, Services, and Codes
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical products; injectable pharmaceutical products; immunoglobulins; injectable immunoglobulins
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical products; injectable pharmaceutical products; immunoglobulins; injectable immunoglobulins |
| GS0051 | Pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Injectable pharmaceutical products, namely, injectable pharmaceuticals for the prevention and treatment of immune system related diseases and disorders; Immunoglobulins for preventing and treating immune system related diseases and disorders; Injectable immunoglobulins for preventing and treating immune system related diseases and disorders |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| APPLICATION FILING RECEIPT MAILED | 2022-09-06 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-09-02 | |
| SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | 2022-09-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 